SOURCE: BioteQ Environmental Technologies Inc.

BioteQ Environmental Technologies Inc.

November 12, 2015 16:00 ET

BioteQ to Commence Trading on TSX Venture Exchange

VANCOUVER, BC--(Marketwired - November 12, 2015) - BioteQ Environmental Technologies Inc. (TSX: BQE), a leader in the treatment of mine impacted waters, has received approval to list its common shares on the TSX Venture Exchange (the "TSX-V"). BioteQ's common shares will continue to trade under the symbol "BQE" and will be listed and posted for trading at the opening of the TSX-V on Friday, November 13, 2015. The Company's common shares will be delisted from the Toronto Stock Exchange at end of trading on Thursday, November 12, 2015.

BioteQ Corporate Profile

BioteQ is a service provider that specializes in treating mining wastewater and specific hydrometallurgical streams with the focus on reducing Life Cycle Costs while achieving compliance and introducing sustainability into water management. We have extensive expertise and operations experience in sulphide precipitation, ion exchange, alkali/lime neutralization and SART process technologies. Over the past decade, BioteQ has designed and commissioned plants at mine sites for leading organizations including Glencore Canada, Freeport McMoRan, Jiangxi Copper and the US EPA and is currently operating six plants under long-term contracts. These plants remove dissolved metals and sulphate to well below the required regulatory discharge limits while reducing or eliminating the production of waste sludge and/or recovering valuable metals from waste streams for sale which reduces the life cycle cost of water treatment. BioteQ is headquartered in Vancouver, Canada and trades on the TSX under the symbol BQE. Please visit our website at www.bioteq.ca for additional information.

The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.

Contact Information

  • For further information please contact:
    BioteQ Environmental Technologies
    Suite 1000 - 1050 West Pender Street
    Vancouver BC Canada V6E 3S7

    David Kratochvil, President & CEO
    dkratochvil@bioteq.ca

    Paul Kim, CFO
    pkim@bioteq.ca

    t 604.685.1243 or 1.800.537.3073